Showing results for 
Search instead for 
Did you mean: 

BLOG: The PSA Test

Community Manager
Community Manager
0 0 493

The PSA Test

Prostate specific antigen (PSA) is an enzyme produced only in the prostate and acts on a protein in semen called seminogelin to give the semen a more liquid consistency. PSA shows up in the blood when sampled. Prostate cancer can raise the level of PSA in the blood but so can age related prostate enlargement causing trouble with urination (benign prostatic hypertrophy); infections (prostatitis); surgical procedures (prostate biopsy, cystoscopy) and natural increase with age. The PSA level may be reduced in those men taking medications such as dutasteride or finasteride (to treat benign prostatic hypertrophy), when testosterone levels are low (for those taking androgen deprivation therapy), following a prostatectomy or radiation therapy.

There are several different laboratory assays that can measure PSA and the reference values may vary between labs. It is always advisable to refer to the reference values for the laboratory where a blood test is done. The “normal” range for PSA for those aged between 40-49 is 0-2.5; up to 3.5 for ages 50-59; up to 4.5 for ages 60-69 and up to 6.5 for ages 70-79. These “normal” reference values may also vary according to ethnicity.

It is important to note that prostate cancer can be present at any level, even very low PSA levels (which can happen in advanced prostate cancer or specific prostate cancer sub-types). Examination of the prostate by a specialist can improve detection rates of cancer in combination with PSA testing.

 An important point to note about the interpretation of PSA testing is the trend of successive readings. Of interest would be the rate at which the PSA rises and by how much. This is particularly important for those being monitored on active surveillance. PSA velocity is sometimes used by the treating specialist to determine if a rise in PSA is significant and of concern. A formula is used to determine PSA velocity on at least three PSA levels taken at least 6 months apart.

By using the size of the prostate determined by a volume measurement on ultrasound, PSA density can be calculated and used as another marker to suggest whether prostate cancer is present or not.

If there is diagnostic uncertainty, some specialists like to aid their decision making by using the Prostate Health Index. This is also a blood test that measures different components of PSA in the blood to determine the risk of prostate cancer.

PSA is an important diagnostic test but it can also be used to measure response to treatment. This is often spoken about in terms of recurrence. Biochemical recurrence refers specifically to a rise in PSA after primary treatment (surgery, radiation or focal therapy). This may indicate a sign of relapse. Local recurrence refers to cancer identified within the prostate (after ablation or radiation) or at the site where the prostate was before a radical prostatectomy (i.e the point where the bladder is reconnected to the urethra or prostatic bed/fossa). Distant or systemic recurrence refers to cancer detected in distant organs (such as bone).

Monitoring for recurrence after radiation therapy is complex as the prostate is still in-situ and the PSA levels may fluctuate. After a radical prostatectomy the PSA is expected to be undetectable. At 6 weeks after surgery a PSA > 0.2 is suspicious for recurrence and an increasing trend in measurements over time is highly suggestive. Imaging such as PET/CT Scan may help confirm the diagnosis.  The PSA doubling time is a formula calculated by the laboratory and helps determine whether a recurrence is more likely to be local versus systemic.

Researchers are currently developing tests that examine the patient’s individual genetics to look for susceptibility to develop prostate cancer, the type of cancer present and what treatment modalities the cancer will respond to1. Urine (PCA3 test) and even semen are being used as alternative sample mediums to make a diagnosis2,3. For now though, the PSA blood test is still the best and most widely available test we have for making a diagnosis and monitoring treatment outcomes.


  1. Salciccia, S.; Capriotti, A.L.; Laganà, A.; Fais, S.; Logozzi, M.; De Berardinis, E.; Busetto, G.M.; Di Pierro, G.B.; Ricciuti, G.P.; Del Giudice, F.; Sciarra, A.; Carroll, P.R.; Cooperberg, M.R.; Sciarra, B.; Maggi, M. Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes. Int. J. Mol. Sci. 2021, 22, 4367.
  2. Rodríguez SVM, García-Perdomo HA. Diagnostic accuracy of prostate cancer antigen 3 (PCA3) prior to first prostate biopsy: A systematic review and meta-analysis. Can Urol Assoc J. 2020;14(5):E214-219.
  3. Lorente G, Ntostis P, Maitland N et al Lourdes. Semen sampling as a simple, noninvasive surrogate for prostate health screening, Systems Biology in Reproductive Medicine, 2021.







About the Author

Kalli Spencer

MBBCh, FC Urol (SA), MMed (Urol), Dip.Couns (AIPC)

Kalli is an internationally renowned Urological Surgeon, specialising in oncology and robotic surgery. He trained and worked in South Africa, before relocating to Australia where he has worked at Macquarie University Hospital and Westmead Hospital. His passion for what he does extends beyond the operating room, through public health advocacy, education and community awareness of men’s health, cancer and sexuality.

Kalli has been involved with the Prostate Cancer Foundation of Australia for many years, advocating for improved cancer care and facilitating community prostate cancer support groups.


Additional Resources:

Attached to this blog are PDF/Online versions of PCFA evidence-based resources surrounding PSA testing and diagnosis. 

- A guide for newly diagnosed men.

- Should I have a PSA test.

- About your PSA result.

PCAM PSA Testing TV.jpg

Help is Available

Prostate Cancer Specialist Telenursing Service:

If your life has been impacted by prostate cancer, our Specialist Telenursing Service is available to help. If you would like to reach out to the PCFA Prostate Cancer Specialist Telenurse Service for any questions you have about your prostate cancer experience, please phone 1800 22 00 99 Monday - Friday 9am - 5pm, Wednesday 10am-8pm (AEST).


Prostate Cancer Support Groups:

PCFA is proud to have a national network of affiliated support groups in each state and territory of Australia consisting of men and women who have a passion for assisting others who encounter prostate cancer. This network is made up of over 170 affiliated groups who meet locally to provide one-to-one support, giving a vision of life and hope after treatment. Call us on 1800 22 00 99 to find your local group.


MatesCONNECT Telephone-based peer support:

MatesCONNECT is a telephone-based peer support program for men affected by prostate cancer. If you’ve recently been diagnosed with prostate cancer, our MatesCONNECT service can connect you to a trained volunteer who understands what you’re going through. All of our volunteers have been through prostate cancer. Simply call us on 1800 22 00 99 to be connected with a volunteer.


Newly diagnosed? or need to find more information -

Access the PCFA resources here!

House Rules

To help keep this community a welcoming, supportive and caring place we have put together a small list of dos and don'ts for you to think about when posting on our forum, research blog or video gallery. For further information please see our  terms and conditions.

Adhere to PCFA’s five core values of Integrity, Optimism, Compassion, Respect and Commitment.

Our online forum is for you to share experiences with others and does not contain specific medical, counselling or legal advice.  If you require professional advice specific to your individual circumstances we encourage you to see a medical professional, legal professional or counsellor.

No commercial or promotional activity. While members may share information about resources they have found helpful, the PCFA Online Community forum should not be used for the promotion of goods and services. This includes commercial entities passing themselves off as individuals and people who frequently post links to external health professionals or other services.

Be kind to each other - many people using the community are going through a difficult time. A few kind words can go a long way. Please welcome new posters – it can be very nerve-wracking to post on the forum for the first time.

If you or someone you know is suffering from mental health issues, such as depression or anxiety, we encourage you to seek assistance and contact Beyond Blue Tel:1300 224 636 or Lifeline Tel:13 11 14

Speak your mind freely, but please be sensitive to the feelings and experiences of others - you might not always agree, but you can agree to disagree in a peaceful manner.

Don't use offensive language -if a user is found to be using offensive language during their conversations the moderators reserve the right to edit the thread, without warning.

Don't use all capital letters in your posts - it's considered ‘shouting' online and it makes posts difficult to read.

Give each other the benefit of the doubt - please remember that it is all too easy for the tone and meaning of posts to be misinterpreted. Think carefully before replying to a discussion. it It is important to remember that things written rather than said can feel much stronger, so please bear this in mind when reading other people's messages.

Please respect the moderators - their job is to keep the forum safe and constructive so that everybody gets to have his or her fair say.

Stay on topic - try to focus on the original topic. In particular, don't change subject in the middle of an existing thread - just start a new thread.

Read what's already on the forum before posting - you may be repeating what others have already said or asked.

We want PCFA's Online Community to be a secure and helpful environment for all of the community. So please remember that by using PCFA's Online Community you are agreeing to follow our terms and conditions.